MTNB

AMEX · Biotechnology

Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$0.57

+0.01 (+1.41%)

As of Mar 30, 5:15 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +6,817.0% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $0.57

Current
$0.57

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

3,851.8%

Low target

Base Case

$39.33

+6,817.0%

Avg target

Bull Case

$48.65

+8,456.1%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$3.09

-81.6% from high

52-Week Low

$0.47

+19.8% from low

Target vs 52W High

$39.33

+1,172.8% vs high

Next Earnings Report

Apr 13, 2026 · After Market Close

11d

until earnings

Earnings in 11 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%